Clinical trials: Obsessive Compulsive Behavior
Obsessive-compulsive Disorder
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
The investigators are conducting a randomized double-blind placebo-controlled study to assess the efficacy of d-cycloserine augmentation of cognitive-behavioral therapy for the treatment of pediatric obsessive compulsive…
- Trial name
- NCT01411774
- Testing
- Cognitive-behavioral therapy, d-cycloserine
- Where
- 2 sites in United States
- Volunteers
- 142 people, healthy volunteers welcome
- Sponsor
- University of South Florida
Internet Addiction Disorder
Behavioral Interventions to Reduce Social Media Addiction Among School-Going Adolescents in Karachi
Addiction to Social Networking Sites (SNS) is considered a major public health problem and is well recognized around the world with serious social and health-related implications.
- Trial name
- NCT07277621
- Testing
- awareness videos
- Where
- Pakistan
- Volunteers
- 260 people
- Sponsor
- Dow University of Health Sciences
Addiction
Effects of a Manualized Short-term Treatment of Internet and Computer Game Addiction
The purpose of this study is to 1) determine the efficacy of manualized Short-term Treatment of Internet and Computer game Addiction (STICA), assess 2) the durability of treatment response in these patients and 3) the impact on…
- Trial name
- STICA (NCT01434589)
- Testing
- STICA Intervention
- Where
- 4 sites in Austria, Germany
- Volunteers
- 187 people
- Sponsor
- Johannes Gutenberg University Mainz
Mukbang
Correlation of Mukbang Video Watching Behavior,Internet Addition and Mental Health Among Adolescent and Youth
The mental health and Internet addiction problems of adolescents and youth can not be ignored and need to be solved urgently. The behavior of watching "Mukbang" videos may be in a mediating position between the two, and its…
- Trial name
- NCT05478395
- Testing
- Questionnaires set
- Where
- China
- Volunteers
- 1,035 people, healthy volunteers welcome
- Sponsor
- Sun Yat-sen University
Obsessive-Compulsive Disorder
A Controlled Trial of Daily Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
Pediatric obsessive-compulsive disorder (OCD) is a chronic and often disabling illness with an estimated lifetime prevalence of 1 to 3%.
- Trial name
- NCT00369642
- Testing
- Cognitive-behavioral therapy
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- University of South Florida
Brief Psychosocial Intervention
Psychosocial Support for Nitrous Oxide Misuse
Nitrous oxide (laughing gas, N₂O) is the third most commonly used recreational drug among young people in the UK. Although it may seem harmless, frequent use can damage the nerves and spinal cord.
- Trial name
- NCT07716293
- Testing
- Psychosocial intervention
- Where
- United Kingdom
- Volunteers
- 10 people
- Sponsor
- Queen Mary University of London
Psychotherapy Intervention Evaluation
iCBT for Children and Adolescents With Obsessive-compulsive Disorder II
Internet-based psychotherapy for children and adolescents with obsessive-compulsive symptoms and an age of 6 to 18 years. Sessions are verified with teleconferencing with an psychotherapist, children and their parents.
- Trial name
- NCT05037344
- Testing
- Cognitive-behavioral psychotherapy
- Where
- Germany
- Volunteers
- 60 people
- Sponsor
- University Hospital Tuebingen
Obsessive-Compulsive Disorder
Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder
The goal of this clinical trial is to evaluate the preliminary outcomes of concentrated exposure and response prevention for children with obsessive-compulsive disorder (OCD) in regular clinical practice.
- Trial name
- NCT06621381
- Testing
- Concentrated exposure and response prevention
- Where
- Sweden
- Volunteers
- 20 people
- Sponsor
- Uppsala University Hospital
Asperger's Disorder, Asperger Disorder
QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360)
BRIEF SUMMARY A. "What is the purpose of this study?" BACKGROUND. The QAIAx clinical trial (Quantum AI/AGI Public Health Agency), known operationally as the "AI City Hall Project," represents a landmark intergovernmental research…
- Conditions
- Asperger's Disorder, Asperger Disorder, Autism Disorder, Autism
- Trial name
- QAIAx (NCT07661823)
- Testing
- AI City Hall Project (AIhealth4u - Public Health Central), AI City Hall Project (QAIAx Microcity A - AI Public Health Central)
- Where
- United States
- Volunteers
- 1,000,000 people, healthy volunteers welcome
- Sponsor
- Veterans Recovery Network Inc.